Alchorne M M, Paschoalick R C, Forjaz M H
Clin Ther. 1987;9(4):360-7.
An eight-week comparative study of tioconazole and clotrimazole was carried out in 32 patients with tinea versicolor. Sixteen patients were treated with 1% tioconazole lotion and 16 with 1% clotrimazole solution; each drug was applied twice daily for 28 days. Clinical and mycological direct examinations were performed before treatment and on days 7, 14, and 28 of therapy. All patients underwent overall clinical evaluation 30 days posttreatment. At the end of the study, all patients were clinically and mycologically cured. During the second week of treatment, however, a significant remission in rash (P less than 0.05) was observed in the group treated with tioconazole. None of the treated patients had adverse reactions. Tioconazole is a new imidazolic agent with an intense fungicidal action. It has been found to be effective and safe and is an agent of choice for treating tinea versicolor.
对32例花斑癣患者进行了为期8周的酮康唑与克霉唑对比研究。16例患者使用1%酮康唑洗剂治疗,16例患者使用1%克霉唑溶液治疗;每种药物均每日涂抹两次,共28天。在治疗前以及治疗的第7、14和28天进行临床和真菌直接检查。所有患者在治疗后30天接受全面临床评估。研究结束时,所有患者临床和真菌学均治愈。然而,在治疗的第二周,酮康唑治疗组皮疹有显著缓解(P<0.05)。所有接受治疗的患者均未出现不良反应。酮康唑是一种新型咪唑类药物,具有强烈的杀菌作用。已发现其有效且安全,是治疗花斑癣的首选药物。